With no recorded cases of Ebola, many Kenyans are struggling to understand why their government is allowing the United States to build an Ebola facility in their country to treat US citizens. Despite ...
- Novel, oral opaganib, delivered a statistically significant increase in survival time (at 150 mg/kg BID) in a U.S. Army-funded in vivo Ebola virus study - Opaganib is believed to be the first ...
Agence France-Presse on MSN
Kenyans fearful and furious over US Ebola centre
In a town overlooked by picturesque Mount Kenya, locals are angry and afraid over their government allowing the United States ...
President Donald Trump’s administration is planning to send Americans who are exposed to Ebola while abroad to a new facility ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results